grant

Developing Immunogens to Elicit Broadly Neutralizing anti-HIV-1 Antibodies

Organization CALIFORNIA INSTITUTE OF TECHNOLOGYLocation PASADENA, UNITED STATESPosted 10 Feb 2013Deadline 31 Dec 2028
NIHUS FederalResearch GrantFY2025AIDSAIDS/HIVAb responseAcquired Immune DeficiencyAcquired Immune Deficiency SyndromeAcquired Immunodeficiency SyndromeAffectAffinityAnimal ModelAnimal Models and Related StudiesAnimalsAnti-Retroviral AgentsAntibodiesAntibody FormationAntibody ProductionAntibody ResponseAntigenic DeterminantsAntigensAntiseraAssayAttenuatedB blood cellsB cellB cellsB-CellsB-LymphocytesB-cellBinding DeterminantsBinding SitesBioassayBioinformaticsBiological AssayClinical Treatment MoabCollaborationsCombining SiteDNA mutationDataDevelopmentDomestic RabbitDrugsELISAElectron MicroscopyEngineeringEnzyme-Linked Immunosorbent AssayEpitope MappingEpitopesEventEvolutionFailureFeedbackFundingGenetic ChangeGenetic defectGenetic mutationGerm LinesGerminal CenterGlycansGoalsHIV vaccineHIV-1HIV-1 vaccineHIV-IHIV/AIDSHIV/AIDS VaccinesHIV1HIV1 vaccineHelper CellsHelper T-CellsHelper T-LymphocytesHelper-Inducer T-CellsHelper-Inducer T-LymphocyteHumanHuman Immunodeficiency Virus Type 1Human immunodeficiency virus 1Immune SeraImmunizationImmunochemical ImmunologicImmunologicImmunologicalImmunologicallyImmunologicsImpairmentInducer CellsInducer T-LymphocytesLaboratoriesLeftM mulattaM. mulattaMacaca mulattaMacaca rhesusMedicationMembraneMemory B CellMemory B-LymphocyteMessenger RNAMiceMice MammalsModelingModern ManMolecularMonoclonal AntibodiesMurineMusMutationOryctolagus cuniculusOutcomePathway interactionsPersonsPharmaceutical PreparationsPhylogenetic AnalysisPhylogeneticsPolysaccharidesPrimatesPrimates MammalsProteinsPublic HealthPublicationsRNA vaccineRNA-based vaccineRabbitsRabbits MammalsReactive SiteRegimenResearchRhesus MacaqueRhesus MonkeySHIVScientific Advances and AccomplishmentsScientific PublicationStructure of germinal center of lymph nodeTestingTransgenic MiceVaccinationVaccine DesignVaccine ResearchVaccinesViralVirusanti-retroviralantibody biosynthesisattenuateattenuatesbiophysical analysisbiophysical studiesbooster dosebooster shotbooster vaccinechallenge in rhesus macaquesdesigndesigningdevelopmentaldrug/agentenzyme linked immunoassayexperimentexperimental researchexperimental studyexperimentsgenome mutationhuman immunodeficiency virus vaccineimmune serumimmunogenimmunogenicityimmunoglobulin biosynthesisimprovedinfected rhesus macaquesinfected rhesus monkeyinfection in rhesus macaquesinfection of rhesus macaquesmAbsmRNAmRNA lipid nano particle vaccinemRNA vaccinemRNA-LNP based vaccinemRNA-LNP combination vaccinesmRNA-LNP vaccinesmRNA-based vaccinemembrane structuremodel of animalmonoclonal Absnano particlenano-sized particlenanoparticlenanosized particleneutralizing antibodynext generationnovelpathwaypressurepreventpreventingprotection pathwayprotective pathwayprotein expressionrecruitresponserhesus challengerhesus macaque challengerhesus monkey infectionscaffoldscaffoldingscientific accomplishmentsscientific advancesscreeningscreeningssimian HIVsimian human immunodeficiency virussynergismtoolvaccine boostvaccine platformvaccine-related research
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Description preview

PROJECT SUMMARY
A central goal in HIV/AIDS vaccine research is the elicitation of broadly neutralizing antibodies (bNAbs). During

the previous funding period, the Bjorkman lab used novel design strategies to develop HIV-1 envelope (Env)

trimer-based immunogens to elicit bNAbs against single and multiple epitopes, including the V3 glycan patch,

CD4…

🔒

Full details available on the Agency plan

Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.

Start 7-day free trial — $29.99/mo →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →
Developing Immunogens to Elicit Broadly Neutralizing anti-HIV-1 Antibodies — CALIFORNIA INSTITUTE OF TECHNOLOGY | UNITED | Dev Procure